Welborn, Michelle Cameron http://orcid.org/0000-0002-9422-6849
Coghlan, Ryan
Sienko, Susan
Horton, William
Funding for this research was provided by:
Shriners Hospitals for Children
Pediatric Orthopaedic Society of North America
Article History
Received: 21 January 2020
Accepted: 21 November 2020
First Online: 5 January 2021
Compliance with ethical standards
:
: Dr. Welborn reports grants from POSNA, grants from Shriners Hospital for Children, during the conduct of the study; personal fees and other from Depuy Synthes, personal fees from Nuvasive, personal fees from Stryker/K2M, outside the submitted work. Mr. Coghlan reports grants from POSNA, grants from Shriners Hospital for Children, during the conduct of the study; personal fees from BioMarin, personal fees from Therachon, personal fees from QED therapeutics outside the submitted work. Dr. Sienko reports grants from POSNA, grants from Shriners Hospital for Children, during the conduct of the study. Dr. Horton reports grants from POSNA, grants from Shriners Hospital for Children, during the conduct of the study; personal fees from Biomarin, personal fees from Ascendis Pharma, personal fees from Theracon, personal fees from QED Therapeutics, personal fees from Relay Therapeutics, outside the submitted work.
: This is a Western IRB approved study.
: Informed consent was obtained from all patients and their parents.